TXN and breast carcinoma: Recently, some studies have provided evidence that activation of GSH production or thioredoxin system in cancer cells might exert counteractive effects on cancer treatments including chemotherapy [29, 30], while targeting the antioxidant enzyme such as catalase could inhibit CSCs in breast cancer and improve therapeutic efficacy [31].